-- Moderna (MRNA) reported a Q1 net loss Friday of $3.40 per diluted share, widening from a loss of $2.52 a year earlier.
Analysts polled by FactSet expected a loss of $4.45.
Revenue for the quarter ended March 31 was $389 million, up from $108 million a year earlier.
Analysts surveyed by FactSet expected $236.4 million.
For 2026, the company said it continues to target 10% revenue growth year over year. Analysts polled by FactSet expect $2.10 billion.
Shares of the company were over 8% higher in Friday premarket activity.
Price: $49.71, Change: $+3.85, Percent Change: +8.38%